Designer Stem Cells Power New R&D Assay Systems

by admin | Aug 11, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by By Kathy Liszewski – Genetic Engineering & Biology News – Novel allogeneic stem cells and differentiated iPSCs are providing more physiologically relevant disease models From axolotls to zebrafish, stem cells possess remarkable regenerative...

Slashing NIH funding imperils the foundation of medical research

by admin | Aug 8, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Bobby Mukkamala, MD – AMA – For more than a century, NIH-sponsored research has played a critical role in improving the nation’s health. This vital work must continue. It’s not hyperbole to say my sudden brain cancer diagnosis last fall could have put a...

Mayo Clinic treats first person in the US with a novel radiopharmaceutical therapy for breast cancer

by admin | Aug 7, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Brittany Cordeiro – Mayo Clinic – ROCHESTER, Minn. — Mayo Clinic has treated the first person in the U.S. using a novel radioactive medicine for advanced breast cancer as part of an international multisite clinical trial. The medicine used in this...

Novel, Less Toxic, Stem Cell Transplant Prep Yields Successful Outcomes

by admin | Aug 6, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Genectic Engineering & Biotechnology – Phase I clinical trial results suggest that an antibody treatment, used in combination with other drugs, enabled stem cell transplants for three children with Fanconi anemia without toxic busulfan chemotherapy or...

Adipose-derived mesenchymal stromal/stem cells in type 1 diabetes treatment

by admin | Aug 5, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Nature Communications Biology – Adipose tissue-derived mesenchymal stromal/stem cells (ADMSCs) represent a novel therapeutic intervention for Type 1 Diabetes (T1D). The attractiveness of ADMSCs is characterized by their immunomodulatory activities,...

Sarepta fails to win EU backing for muscle disorder gene therapy

by admin | Aug 4, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Christy Santhosh – Reuters News – Sarepta Therapeutics (SRPT.O), failed to win the European drug regulator’s backing for its muscle disorder gene therapy on Friday, as the company faces intense regulatory scrutiny after two recent patient deaths...